Literature DB >> 9134233

Direct cardiac and vascular actions of adrenomedullin in conscious sheep.

D G Parkes1, C N May.   

Abstract

1. Adrenomedullin (ADM) is a recently characterized circulating hormone which affects haemodynamic, renal and pituitary function in mammals. We have shown previously that in sheep, ADM produces vasodilatation together with increases in cardiac output and contractility. However, whether these effects are direct or mediated by autonomic reflexes is unclear. The present study examined the cardiovascular actions of an intravenous infusion of ADM in conscious, chronically instrumented sheep with either sympathetic, parasympathetic or autonomic ganglion blockade, to determine the role of the autonomic nervous system in mediating these cardiovascular changes. 2. Human ADM (1-52) was infused for 60 min at 2 micrograms kg-1 h-1 following: (1) saline control, (2) combined alpha/beta-adrenoceptor (sympathetic) blockade (proporanolol 0.4 mg kg-1 h-1 + phentolamine 0.15 mg kg-1 h-1 for 20 h), (3) muscarinic (parasympathetic) blockade (methscopolamine 0.05 mg kg-1 h-1 for 20 h) or (4) ganglion blockade (hexamethonium 3 mg kg-1 h-1 for 4 h). Measurements were made of mean arterial pressure (MAP), heart rate (HR), cardiac output (CO), stroke volume (SV), total peripheral conductance (TPC), maximal aortic flow (Fmax) and maximal rate of change of aortic flow (dF/dt). 3. ADM reduced MAP by 3 +/- 1 mmHg, and increased CO (1.2 +/- 0.2 l min-1), HR (14 +/- 2 beats min-1), TPC (21 +/- 3 ml min-1 mmHg-1). Fmax (2.3 +/- 0.8 l min-1) and dF/dt (86 +/- 21 l min-1 s-1) in normal sheep. In animals with alpha/beta blockade, similar changes were observed with ADM. However, during muscarinic blockade, the increases in HR (32 +/- 4 beats min-1), CO (2.1 +/- 0.4 l min-1), TPC (31 +/- 4 ml min-1 mmHg-1). Fmax (4.0 +/- 0.6 l min-1), and dF/dt (150 +/- 12 l min-1 s-1) produced by ADM were enhanced. During ganglion blockade, ADM produced a greater reduction in MAP (-10 +/- 2 mmHg) compared to controls (-3 +/- 1 mmHg). However, there was no increase in HR. The changes in CO, TPC and contractility were similar to those observed in control animals. 4. These results suggest that the vasodilator effects of ADM on the periphery and its ability to increase CO and cardiac contractility are not mediated by the autonomic nervous system, but are probably the result of direct actions of ADM on the heart and vasculature.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9134233      PMCID: PMC1564583          DOI: 10.1038/sj.bjp.0701034

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  11 in total

1.  Prognostic value of plasma MR-proADM vs NT-proBNP for heart failure in people with type 2 diabetes: the SURDIAGENE prospective study.

Authors:  Mathilde Fraty; Gilberto Velho; Elise Gand; Fréderic Fumeron; Stéphanie Ragot; Philippe Sosner; Kamel Mohammedi; Barnabas Gellen; Pierre-Jean Saulnier; Jean-Michel Halimi; David Montaigne; Grégory Ducrocq; Michaela Rehman; Michel Marre; Ronan Roussel; Samy Hadjadj
Journal:  Diabetologia       Date:  2018-09-19       Impact factor: 10.122

2.  Adrenomedullin reduces vascular hyperpermeability and improves survival in rat septic shock.

Authors:  Bettina Temmesfeld-Wollbrück; Bernhard Brell; István Dávid; Martin Dorenberg; Jörn Adolphs; Bernd Schmeck; Norbert Suttorp; Stefan Hippenstiel
Journal:  Intensive Care Med       Date:  2007-02-22       Impact factor: 17.440

Review 3.  Biomarkers in acute myocardial infarction.

Authors:  Daniel Chan; Leong L Ng
Journal:  BMC Med       Date:  2010-06-07       Impact factor: 8.775

4.  Direct coronary vasodilator action of adrenomedullin is mediated by nitric oxide.

Authors:  R De Matteo; C N May
Journal:  Br J Pharmacol       Date:  2003-11-17       Impact factor: 8.739

5.  Role of point of care - ST2, Galectin-3 and adrenomedullin in the evaluation and treatment of emergency patients.

Authors:  Angela Siler-Fisher; Veronica Tucci; Sarathi Kalra; Sagar C Galwankar; Swapnil D Khose; S Sanjeevani; Ashish Goel; Frank W Peacock
Journal:  Int J Crit Illn Inj Sci       Date:  2014-07

6.  The Role of Adrenomedullin in Cardiovascular Response to Exercise - A Review.

Authors:  Krzysztof Krzeminski
Journal:  J Hum Kinet       Date:  2016-10-14       Impact factor: 2.193

Review 7.  Adrenomedullin and Adrenomedullin-Targeted Therapy As Treatment Strategies Relevant for Sepsis.

Authors:  Christopher Geven; Matthijs Kox; Peter Pickkers
Journal:  Front Immunol       Date:  2018-02-19       Impact factor: 7.561

8.  Adrenomedullin 2 increases cardiac sympathetic nerve activity in parallel to heart rate in normal conscious sheep.

Authors:  Christopher J Charles; David L Jardine; Miriam T Rademaker; A Mark Richards
Journal:  Physiol Rep       Date:  2019-05

Review 9.  Promotion of vascular integrity in sepsis through modulation of bioactive adrenomedullin and dipeptidyl peptidase 3.

Authors:  D van Lier; M Kox; P Pickkers
Journal:  J Intern Med       Date:  2020-12-30       Impact factor: 8.989

10.  Pro-Adrenomedullin predicts 10-year all-cause mortality in community-dwelling patients: a prospective cohort study.

Authors:  Jonas Odermatt; Marc Meili; Lara Hersberger; Rebekka Bolliger; Mirjam Christ-Crain; Matthias Briel; Heiner C Bucher; Beat Mueller; Philipp Schuetz
Journal:  BMC Cardiovasc Disord       Date:  2017-07-04       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.